Lv1
48 积分 2026-05-09 加入
Population-based survival trends for ER-/HER2+ metastatic breast cancer in the United States, 2000–2023
14小时前
求助中
Goserelin
22天前
已完结
Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease
26天前
已完结
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study
1个月前
已关闭
皖公网安备34019202002308
